Clinical Trials Directory

Trials / Sponsors / Faron Pharmaceuticals Ltd

Faron Pharmaceuticals Ltd

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard o
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
Phase 1 / Phase 22022-06-02
WithdrawnA Phase I/II Open Label Single Centre Trial to Assess the Safety, Tolerability and Efficacy of Single Dose Neo
Carcinoma, Renal Cell, Carcinoma Colon
Phase 1 / Phase 22021-10-07
TerminatedHuman Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19
Covid19
Phase 22021-08-23
CompletedA Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)
Cancer
Phase 1 / Phase 22018-12-03
TerminatedEfficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After
Preventive Medicine, Multi Organ Failure
Phase 22017-02-18
TerminatedEfficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome
Respiratory Distress Syndrome, Adult
Phase 32015-12-23
CompletedSafety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II
Acute Lung Injury, Acute Respiratory Distress Syndrome
Phase 1 / Phase 22009-02-01